Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Sonic Healthcare Limited
  6. News
  7. Summary
    SHL   AU000000SHL7

SONIC HEALTHCARE LIMITED

(SHL)
  Report
End-of-day quote. End-of-day quote Australian Stock Exchange - 11/30
42.7 AUD   0.00%
11/24SONIC HEALTHCARE : Notification regarding unquoted securities - SHL
PU
11/22Morgans rates SHL as Add
AQ
11/18Bruxelles Lambert, Others Bid For $5 Billion Diagnostics Firm Unilabs
MT
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Sonic Healthcare Annual Profit More Than Doubles

08/22/2021 | 05:01pm EST

By David Winning

SYDNEY--Sonic Healthcare Ltd. said its annual profit more than doubled, as revenue from conducting coronavirus tests more than offset pandemic-related disruptions to some other services that it provides across its global network.

Sonic said its net profit totaled 1.32 billion Australian dollars (US$942 million) in the 12 months through June, up from A$527.7 million a year earlier. Directors of the company declared a final dividend of 55 Australian cents a share, up 7.8% on a payout of 51 cents a year earlier.

The global spread of the Delta variant of coronavirus is reinvigorating demand for tests to detect new inflections just as investors had begun to worry that an acceleration in vaccination rates would make them less vital. Countries such as Australia and New Zealand, which had previously had low or zero Covid-19 cases, are now battling to contain outbreaks.

On Monday, Sonic said Covid-19 testing had provided a significant boost to revenue and earnings during fiscal 2021, with around 30 million tests performed in its global network of laboratories. It said revenue rose by 28% to A$8.8 billion. Stripping out the revenue windfall from the tests, Sonic said revenue from its base business rose by 6%.

Sonic said its balance sheet was "set for growth by acquisition," with gearing at a record low and A$1.5 billion of liquidity available.

Write to David Winning at david.winning@wsj.com

(END) Dow Jones Newswires

08-22-21 1901ET

All news about SONIC HEALTHCARE LIMITED
11/24SONIC HEALTHCARE : Notification regarding unquoted securities - SHL
PU
11/22Morgans rates SHL as Add
AQ
11/18Bruxelles Lambert, Others Bid For $5 Billion Diagnostics Firm Unilabs
MT
11/18SONIC HEALTHCARE : Notification regarding unquoted securities - SHL
PU
11/17SONIC HEALTHCARE : 2021 AGM - CEO Presentation
PU
11/11Application for quotation of securities - SHL
PU
11/09Sonic Healthcare Corporate Responsibility Report 2021
PU
10/21THE WRAP : Stagflation? Asian Savings Slump, Insurers & Healthcare
AQ
10/06Banks and healthcare stocks lift Australian shares
RE
09/07SONIC HEALTHCARE LIMITED : Ex-dividend day for final dividend
FA
More news
Financials
Sales 2022 8 786 M 6 285 M 6 285 M
Net income 2022 1 250 M 894 M 894 M
Net Debt 2022 453 M 324 M 324 M
P/E ratio 2022 16,6x
Yield 2022 2,68%
Capitalization 20 482 M 14 532 M 14 651 M
EV / Sales 2022 2,38x
EV / Sales 2023 2,59x
Nbr of Employees 38 000
Free-Float 95,8%
Chart SONIC HEALTHCARE LIMITED
Duration : Period :
Sonic Healthcare Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SONIC HEALTHCARE LIMITED
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 14
Last Close Price 42,70 AUD
Average target price 43,33 AUD
Spread / Average Target 1,48%
EPS Revisions
Managers and Directors
Colin Stephen Goldschmidt Chief Executive Officer, MD & Executive Director
Christopher David Wilks CFO, Finance Director & Executive Director
Mark R. Compton Chairman
Louis James Panaccio Independent Non-Executive Director
Kathryn Dianne Spargo Independent Non-Executive Director
Sector and Competitors